Vita 34 AG (V3V) NPV
Vita 34 AG, is a Germany-based company that operates as an umbilical cord blood bank. It operates through the Stem Cell Storage and the Biotechnology segment. The Stem Cell Storage segment collects, processes, and stores stem cells from umbilical cord blood and umbilical cord tissue, as well as develops cell therapy procedures. The Biotechnology segment develops biological processes for cell and tissue culture, as well as employs them in the optimization and multiplication of cells and plants. It offers VitaPlusDonation that offers parents an alternative to the purely autologous storage or allogenic donation of umbilical cord blood; and Sibling Initiative program, which allows the storage free of charge of stem cells from the umbilical cord of a child whose brother or sister is seriously ill. The Company also provides prevention screening that helps to detect genetically related health risks and predispositions.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.